This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Accro Bioscience (Hk) Limited, Accro Bioscience Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Sudan He: Innovator in Heteroaryl Compounds
Introduction
Sudan He is a notable inventor based in Suzhou, China, with a focus on the development of innovative pharmaceutical compounds. He has been awarded two patents that underline his contributions to the field of medicinal chemistry, particularly in the treatment of diseases associated with necrosis.
Latest Patents
His latest patents, titled "Heteroaryl Compounds as Inhibitors of Necrosis, Composition and Method Using the Same" and "Heteroaryl Compounds as Inhibitors of Necrosis, Composition and Application Thereof," detail novel heteroaryl compounds characterized by their potential therapeutic applications. These patents describe various processes for the preparation of these compounds, their pharmaceutical formulations, and their applications in treating diseases and disorders arising from or related to necrosis.
Career Highlights
Sudan has worked with reputable organizations, including Accro Bioscience (HK) Limited and Accro Bioscience Inc., where he has contributed significantly to research and development in the pharmaceutical sector. His work in these companies demonstrates his commitment to advancing scientific knowledge and creating innovative solutions for health-related challenges.
Collaborations
Throughout his career, Sudan has collaborated with esteemed colleagues, including Xiaohu Zhang and Haikuo Ma. These collaborations have enabled him to share ideas, enhance research outputs, and push the boundaries of what is achievable in pharmaceutical innovation.
Conclusion
Sudan He's contributions to the field of medicinal chemistry are marked by his inventive spirit and dedication to improving health outcomes through innovation. With two patents under his name, he continues to influence the landscape of therapeutic development and stands as a significant figure in the world of inventions related to necrosis treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile